100
Participants
Start Date
June 1, 2016
Primary Completion Date
February 22, 2021
Study Completion Date
April 15, 2021
ViviGen
ViviGen Cellular Bone Matrix is a formulation of cryopreserved viable cortical cancellous bone matrix and demineralized bone. ViviGen is a Human Cells, Tissues, and Cellular and Tissue-based Product (HCT/P) as defined by the U.S. Food and Drug Administration in 21 CFR 127 1.3(d).
Lead Sponsor
DePuy Spine
INDUSTRY